Literature DB >> 30470547

Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development.

Janine K Tom1, Tyler J Albin1, Saikat Manna2, Brittany A Moser2, Rachel C Steinhardt2, Aaron P Esser-Kahn3.   

Abstract

Pathogens comprise a diverse set of immunostimulatory molecules that activate the innate immune system during infection. The immune system recognizes distinct combinations of pathogenic molecules leading to multiple immune activation events that cooperate to produce enhanced immune responses, known as 'immune synergies'. Effective immune synergies are essential for the clearance of pathogens, thus inspiring novel adjuvant design to improve vaccines. We highlight current vaccine adjuvants and the importance of immune synergies to adjuvant and vaccine design. The focus is on new technologies used to study and apply immune synergies to adjuvant and vaccine development. Finally, we discuss how recent findings can be applied to the future design and characterization of synergistic adjuvants and vaccines.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  adjuvant; antigen; immune synergy; immunology; vaccine

Year:  2018        PMID: 30470547     DOI: 10.1016/j.tibtech.2018.10.004

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  24 in total

1.  Computational tools for modern vaccine development.

Authors:  Andaleeb Sajid; Yogendra Singh; Pratyoosh Shukla
Journal:  Hum Vaccin Immunother       Date:  2019-12-18       Impact factor: 3.452

2.  Polysaccharide PCP-I isolated from Poria cocos enhances the immunogenicity and protection of an anthrax protective antigen-based vaccine.

Authors:  Kun Liu; Ying Yin; Jun Zhang; Xiaodong Zai; Ruihua Li; Hao Ma; Junjie Xu; Junjie Shan; Wei Chen
Journal:  Hum Vaccin Immunother       Date:  2019-12-06       Impact factor: 3.452

Review 3.  Immunogenicity and Reactogenicity in Q Fever Vaccine Development.

Authors:  Alycia P Fratzke; Erin J van Schaik; James E Samuel
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

Review 4.  Peptides for Vaccine Development.

Authors:  Ian W Hamley
Journal:  ACS Appl Bio Mater       Date:  2022-02-23

5.  Rational design of innate defense regulator peptides as tumor vaccine adjuvants.

Authors:  Yaomei Tian; Qiuyue Hu; Rui Zhang; Bailing Zhou; Daoyuan Xie; Yuanda Wang; Xueyan Zhang; Li Yang
Journal:  NPJ Vaccines       Date:  2021-05-20       Impact factor: 7.344

Review 6.  Resources to Discover and Use Short Linear Motifs in Viral Proteins.

Authors:  Peter Hraber; Paul E O'Maille; Andrew Silberfarb; Katie Davis-Anderson; Nicholas Generous; Benjamin H McMahon; Jeanne M Fair
Journal:  Trends Biotechnol       Date:  2019-08-16       Impact factor: 19.536

7.  Adamantane Containing Peptidoglycan Fragments Enhance RANTES and IL-6 Production in Lipopolysaccharide-Induced Macrophages.

Authors:  Mateja Manček-Keber; Rosana Ribić; Fernando Chain; Davy Sinnaeve; José C Martins; Roman Jerala; Srđanka Tomić; Krisztina Fehér
Journal:  Molecules       Date:  2020-08-14       Impact factor: 4.411

Review 8.  The Status and Prospects of Epstein-Barr Virus Prophylactic Vaccine Development.

Authors:  Cong Sun; Xin-Chun Chen; Yin-Feng Kang; Mu-Sheng Zeng
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

Review 9.  Toward precision adjuvants: optimizing science and safety.

Authors:  Etsuro Nanishi; David J Dowling; Ofer Levy
Journal:  Curr Opin Pediatr       Date:  2020-02       Impact factor: 2.856

Review 10.  Molecular characterization, pathogen-host interaction pathway and in silico approaches for vaccine design against COVID-19.

Authors:  Nidhi Singh; Sachchida Nand Rai; Veer Singh; Mohan P Singh
Journal:  J Chem Neuroanat       Date:  2020-10-19       Impact factor: 3.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.